Teva Pharmaceutical Industries
TEVA
$8.48
Share price
-0.53%
Change (1 day)
4.62%
Change (1 year)
Categories
Revenue for Teva Pharmaceutical Industries (TEVA)
Revenue in 2022 (TTM): $14.92 B
According to Teva Pharmaceutical Industries's latest financial reports the company's current revenue (TTM) is $14.92 B. In 2021 the company made a revenue of $15.87 B a decrease over the years 2020 revenue that were of $16.65 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Teva Pharmaceutical Industries from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $14.92 B | -6.01% |
| 2021 | $15.87 B | -4.68% |
| 2020 | $16.65 B | -1.37% |
| 2019 | $16.88 B | -10.43% |
| 2018 | $18.85 B | -15.77% |
| 2017 | $22.38 B | 2.2% |
| 2016 | $21.90 B | 11.45% |
| 2015 | $19.65 B | -3.06% |
| 2014 | $20.27 B | -0.21% |
| 2013 | $20.31 B | -0.01% |
| 2012 | $20.31 B | 10.95% |
| 2011 | $18.31 B | 13.59% |
| 2010 | $16.12 B | 15.99% |
| 2009 | $13.89 B | 25.39% |
| 2008 | $11.08 B | 17.83% |
| 2007 | $9.40 B | 11.89% |
| 2006 | $8.40 B | 60.14% |
| 2005 | $5.25 B | 9.41% |
| 2004 | $4.79 B | 46.47% |
| 2003 | $3.27 B | 30.09% |
| 2002 | $2.51 B | 21.24% |
| 2001 | $2.07 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $51.82 B | 247.28% | 🇨🇭 Switzerland |
 Pfizer PFE | $100.33 B | 572.28% | 🇺🇸 USA |
 Sanofi SNY | $47.62 B | 219.12% | 🇫🇷 France |
 Merck MRK | $59.28 B | 297.23% | 🇺🇸 USA |
 AstraZeneca AZN | $44.35 B | 197.17% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $38.94 B | 160.93% | 🇬🇧 UK |
 Dr. Reddy's RDY | $2.97 B | -80.10% | 🇮🇳 India |